Answer
The most frequently reported adverse reactions to patisiran sodium (Onpattro) were peripheral oedema (29.7%) and infusion-related reactions (18.9%).
Sources for this answer
- Onpattro 2 mg/mL concentrate for solution for infusion.Alnylam UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 12Document updated
Sources checked